Lymphocyte immune globulin, anti-thy (equine) Disease Interactions
There are 2 disease interactions with lymphocyte immune globulin, anti-thy (equine).
Lymphocyte immune globulin, anti-thy (equine) (applies to lymphocyte immune globulin, anti-thy (equine)) immunocompromised
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency, Vaccination
Do not administer live vaccines to patients about to receive, receiving, or after treatment with lymphocyte immune globulin, anti-thy (equine). Concomitant administration of lymphocyte immune globulin, anti-thy (equine) with live virus vaccines carries a potential of uncontrolled viral replication in the immunosuppressed patient. There is insufficient information to fully define the extent of the risk, or the period of time during which the risk exists. If administered, live viruses may interfere with lymphocyte immune globulin, anti-thy (equine) treatment.
References
- (2010) "Product Information. Atgam (lymphocyte immune globulin, anti-thy (equine))." Pfizer U.S. Pharmaceuticals Group
Lymphocyte immune globulin, anti-thy (equine) (applies to lymphocyte immune globulin, anti-thy (equine)) renal/liver
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction, Liver Disease
The use of lymphocyte immune globulin, anti-thy (equine) in patients with aplastic anemia and other hematologic abnormalities may result in abnormal tests of liver function (SGOT, SGPT, alkaline phosphatase) and renal function (serum creatinine). It is recommended to evaluate these tests closely in these patients.
References
- (2010) "Product Information. Atgam (lymphocyte immune globulin, anti-thy (equine))." Pfizer U.S. Pharmaceuticals Group
Lymphocyte immune globulin, anti-thy (equine) drug interactions
There are 159 drug interactions with lymphocyte immune globulin, anti-thy (equine).
More about lymphocyte immune globulin, anti-thy (equine)
- lymphocyte immune globulin, anti-thy (equine) consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.